Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
NEC: Northgate Public Services Makes Three Acquisitions to Strengthen its International Healthcare Screening Offering - The Pharma Times | Pharma & Health Care News Portal
Categories: Health Care

NEC: Northgate Public Services Makes Three Acquisitions to Strengthen its International Healthcare Screening Offering

London, April 05, 2019 : NEC Corporation (TSE: 6701) and Northgate Public Services (NPS), a wholly owned NEC subsidiary, today announced that NPS acquired three EMIS Group plc businesses for POUND14.9 million, to strengthen its growing screening and preventative healthcare offering.

The three acquired EMIS Group plc businesses, Digital Healthcare Limited, Medical Imaging UK Limited and MIDRSS Limited, have 25 years’ experience in diabetic eye screening, assessing around 50,000 patients every month in 1,200 different locations.

NPS already has a significant presence in this sector, helping to screen 10 million babies for the Newborn Hearing Screening Program in England and Northern Ireland and testing 500,000 patients with diabetes for retina damage and sight loss under Scotland’s Diabetic Screening Programme. These acquisitions will give NPS a screening presence in eight countries across the globe, including the rapidly growing healthcare market in India.

The total cash consideration for the acquisition was POUND 14.9 million, made up of ?14 million paid on completion (inclusive of POUND 5 million of inter company debtor balances settled in cash by EMIS Group on completion) and POUND 0.9 million of contingent consideration.

Stephen Callaghan, chief executive officer of NPS, said, “Uniting our extensive experience in healthcare screening will bring the best possible preventative technology and care to the public, initially in the UK and subsequently in other parts of the world. We are very proud of our existing screening programmes in UK, Ireland and India and are very much looking forward to extending our offering to secure the best possible patient outcomes. Preventative measures, such as screening, will have an increasing role to play in improving health in both the UK and worldwide.”

Lydia Saunders, director and general manager of EMIS Care, said, “Joining the NPS team brings new and exciting prospects for the detection and prevention of serious health conditions to protect the public internationally.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

1 day ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

2 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

3 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

6 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420